Sanofi (SNY) has released an update. Sanofi’s Dupixent has shown promising results in a Phase 3 trial for treating chronic spontaneous urticaria, significantly reducing symptoms like itch and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boone picked Gil over Cole, who started Game 1 on Friday. According to SNY insider Andy Martino, the Yankees have not considered or discussed Cole replacing the Rookie of the Year candidate ...

Sanofi SNY announced that it has entered into an agreement with France-based cancer biotech Orano Med to jointly develop next-generation radioligand therapies for treating rare cancers.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF – Research Report) and Sanofi (SNY – Research Report) with bullish sentiments.

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on SNY: Sanofi NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Amgen releases Phase 3 trial data for rocatinlimab and Uplizna, with analysts projecting strong sales despite competition in the atopic dermatitis and myasthenia gravis markets. Attention shifts ...

Think logos are tacky? No more. Fashion has shifted from giant Gs and Cs to quiet branding that lets men and women subtly ...

Their colors bent from red and yellow, tenured since the early 1970s, to blue, silver and red. The logo’s prismatic font was ...